Smoking history and underlying lung disease are associated with poor outcome in patients developing interstitial pneumonia during low-dose amiodarone therapy

Smoking history and underlying lung disease are associated with poor outcome in patients developing interstitial pneumonia during low-dose amiodarone therapy

Background: Amiodarone is a useful antiarrhythmic drug, especially in patients with serious heart diseases, but amiodarone-induced interstitial pneumonia (AMD-IP) is sometimes lethal. Methods and results: We retrospectively analyzed the clinical characteristics of 280 patients who were treated with...

Full description

Bibliographic Details
Main Authors: Masatsugu Nozoe, MD, PhD, Toshihiro Honda, MD, PhD, Mitsuko Honda, MD, PhD, Kazuya Ichikado, MD, PhD, Moritaka Suga, MD, PhD, Koichi Nakao, MD, PhD
Format: Article
Language:English
Published: Wiley 2013-02-01
Series:Journal of Arrhythmia
Subjects:
Amiodarone
Interstitial pneumonia
Smoking
Chronic obstructive pulmonary disease
Online Access:http://www.sciencedirect.com/science/article/pii/S1880427612000889

Internet

http://www.sciencedirect.com/science/article/pii/S1880427612000889

Similar Items